Clarus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial and Operating Results
March 29, 2022 16:05 ET
|
Clarus Therapeutics Holdings, Inc.
NORTHBROOK, Ill., March 29, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...
BeiGene to Webcast an Analyst and Investor Event from the American Society of Hematology Annual Meeting
December 04, 2017 16:05 ET
|
BeiGene, LTD.
CAMBRIDGE, Mass., and BEIJING, China, Dec. 04, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative...
BeiGene to Participate in Baird and Morgan Stanley Global Healthcare Conferences
August 31, 2016 16:15 ET
|
BeiGene, LTD.
WALTHAM, Mass., Aug. 31, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company focused on developing innovative molecularly-targeted and immuno-oncology...